A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)

NCT06099080 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatosis Papulosa Nigra

Interventions

DRUG: SM-020 gel 1.0%

Sponsor

DermBiont, Inc.